A carregar...
Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy
Targeted therapies such as kinase inhibitors and monoclonal antibodies have dramatically altered cancer care in recent decades. Although these targeted therapies have improved patient outcomes in several cancer types, resistance ultimately develops to these agents. One potential strategy proposed to...
Na minha lista:
| Publicado no: | Genome Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5399860/ https://ncbi.nlm.nih.gov/pubmed/28431544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13073-017-0431-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|